Division of Vascular Surgery, "Vita-Salute" University, Scientific Institute H. San Raffaele, Milan, Italy.
Division of Vascular Surgery, "Vita-Salute" University, Scientific Institute H. San Raffaele, Milan, Italy.
Ann Vasc Surg. 2022 Jan;78:9-18. doi: 10.1016/j.avsg.2021.06.023. Epub 2021 Aug 28.
The best management of renal artery aneurysms (RAAs) remains controversial, especially when they are located from the mid to distal portions of the main renal artery. Our aim is to evaluate our 10-year experience with in situ open surgical repairs from a cohort of non-proximal RAAs at a single vascular surgery center.
A retrospective review of a prospectively maintained database of all patients who underwent RAA in situ repairs located from the mid to distal portions of the renal artery at our Institution was performed between 2009 and 2020. Data on patient demographics, comorbidities, aneurysm location and morphology, type of in situ technique, and perioperative data were assessed. Postoperative biomarkers and renal function were collected, and mid-term follow-up results were analyzed.
A total of 15 RAA located at mid and distal portions of the renal artery repaired with in situ techniques were performed in 15 patients (nine men, mean age 62.4 ± 6.36 years). At diagnosis, 12 patients were asymptomatic; a history of abdominal pain was found in one patient, and two patients had drug-resistant hypertension. Two patients had already undergone previous unsuccessful attempts of endovascular treatment. All patients presented an aneurysm diameter >20 mm (mean diameter 2.75 ± 5 mm). At admission, mean serum creatinine and glomerular filtration rate were 1.10 ± 0.23 mg/dL and 69.8 ± 9.8 mL/min/1.73 m, respectively. Nine lesions were present in the distal portion of the renal artery, with 4 cases having ≥3 efferent branches and the other 5 with two efferent branches. The other six RAAs were in the mid-portion: in 4 cases, one efferent branch, and in 2 cases, two efferent branches were involved. All patients underwent in situ open repair: an end-to-end anastomosis was performed in 9 cases, aneurysm resection with primary closure in 3 cases, bypass with graft interposition in 2 cases (one iliac-renal reconstruction), and with vein interposition in 1 case. The mean renal ischemia time was 21.8 ± 9.4 min. A significant decrease on renal function was not observed (mean glomerular filtration rate at discharge: 64.8 ± 12.0 mL/min/1.73m; P > 0.22). During recovery, one patient developed retroperitoneal hematoma treated conservatively. During follow-up (mean 46 months, range 2-135), one patient developed occlusion of a terminal renal artery branch without decreased kidney function.
In situ techniques for RAA from the mid to distal portions of the renal artery are technically complex; however, based on our results, these procedures were safe and effective, providing satisfactory early and mid-term outcomes.
肾动脉动脉瘤(RAA)的最佳治疗方法仍存在争议,尤其是当它们位于主肾动脉的中至远段时。我们的目的是评估我们在一个血管外科中心对 10 年来非近端 RAA 的原位开放手术修复的经验。
对 2009 年至 2020 年间在我们机构进行的位于肾动脉中至远段的 RAA 原位修复的前瞻性维护数据库进行了回顾性分析。评估了患者人口统计学、合并症、动脉瘤位置和形态、原位技术类型以及围手术期数据。收集了术后生物标志物和肾功能数据,并分析了中期随访结果。
15 名患者的 15 个位于肾动脉中至远段的 RAA 采用原位技术进行了修复(9 名男性,平均年龄 62.4 ± 6.36 岁)。诊断时,12 名患者无症状;1 名患者有腹痛病史,2 名患者有药物抵抗性高血压。2 名患者以前曾进行过不成功的血管内治疗尝试。所有患者的动脉瘤直径均大于 20mm(平均直径 2.75 ± 5mm)。入院时,平均血清肌酐和肾小球滤过率分别为 1.10 ± 0.23mg/dL 和 69.8 ± 9.8mL/min/1.73m。9 个病变位于肾动脉远段,其中 4 例有≥3 个流出分支,另 5 例有 2 个流出分支。另外 6 个 RAA 位于中段:4 例有 1 个流出分支,2 例有 2 个流出分支。所有患者均接受了原位开放修复:9 例采用端对端吻合术,3 例采用动脉瘤切除术和一期修补术,2 例采用旁路移植术(1 例髂肾重建),1 例采用静脉旁路移植术。平均肾脏缺血时间为 21.8 ± 9.4min。肾功能未见明显下降(出院时平均肾小球滤过率:64.8 ± 12.0mL/min/1.73m;P>0.22)。在恢复期间,1 名患者发生了保守治疗的腹膜后血肿。在随访期间(平均随访时间为 46 个月,范围为 2-135 个月),1 名患者出现终末肾动脉分支闭塞,但肾功能无下降。
肾动脉中至远段 RAA 的原位技术较为复杂,但根据我们的结果,这些手术是安全有效的,可提供满意的早期和中期结果。